Skip to main content
. Author manuscript; available in PMC: 2012 Dec 1.
Published in final edited form as: Drug Dev Res. 2011 Dec;72(8):756–763. doi: 10.1002/ddr.20484

Table 1.

Characteristics of Participants.

Variable Total sample (n = 108) Adherent group (n = 98) Non-adherent group (n = 10) p value
Age in years 52 ± 13 52 ± 14 53 ± 9 0.77
Gender female 82 (76%) 75 (76%) 6 (68%) 0.69
Ethnicity
    Caucasian 89 (83%) 84 (86%) 5 (56%) 0.04
    African American/ 14 (13%) 11 (11%) 3 (33%)
    Other 4 (4%) 3 (3%) 1 (11%)
Education in years 13 ± 3 13 ±3 12 ± 3 0.81
Marital status
    Married/cohabit 62 (58%) 56 (57%) 6 (67%) 0.74
    Widowed 7 (7%) 7 (7%) 0
    Divorced/Separated 20 (19%) 19 (19%) 1 (11%)
    Single/ Never Married 18 (17%) 16 (16%) 2 (22%)
Employment
    Employed full-time 27 (26%) 25 (26%) 2 (22%) 0.72
    Employed part-time 7 (7%) 7 (7%) 1 (11%)
    Unemployed 10 (9%) 10 (10%) 0
    Sick leave/disability 35 (33%) 33 (34%) 2 (22%)
    Homemaker 7 (7%) 6 (6%) 1 (11%)
    Retired 20 (19%) 17 (17%) 3 (33%)
Residence location
    Urban 55 (51%) 48 (53%) 7 (78%) 0.18
    Rural 45 (42%) 43 (47%) 2 (22%)
Years since diagnosis 10 ± 10 10 ± 10 11 ± 8 0.73
    Total number of RA medications 2 ± 1 2 ± 1 3 ± 2 0.43

Values are mean + SD or frequency (%), May not total to 100% due to some missing data points

Variables compared with independent t tests or Chi square analyses based on level of measurement

For those variables with no cases in a cell, categories were collapsed to ensure the assumptions of Chi square were met prior to analysis